Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
07/2003
07/10/2003WO2003055915A2 Human netrin receptor and uses thereof
07/10/2003WO2003055913A2 Secreted protein
07/10/2003WO2003055912A2 Secreted proteins
07/10/2003WO2003055910A1 Beta-amyloid binding factors and inhibitors thereof
07/10/2003WO2003055882A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
07/10/2003WO2003055877A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
07/10/2003WO2003055876A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
07/10/2003WO2003055875A1 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
07/10/2003WO2003055874A1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor
07/10/2003WO2003055863A1 Novel alkansulfonamides as endothelin antagonists
07/10/2003WO2003055505A2 Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders
07/10/2003WO2003055504A1 Pharmaceutical composition for prevention and treatment of premature ejaculation and/or hypersensitivity of sexual stimulation
07/10/2003WO2003055499A1 Use of sulfated glycosaminoglycans for establishing effective labor in women
07/10/2003WO2003055498A1 Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std)
07/10/2003WO2003055495A1 ORAL PHARMACEUTICAL PRODUCTS CONTAINING 17β-ESTRADIOL-3-LOWER ALKANOATE, METHOD OF ADMINISTERING THE SAME AND PROCESS OF PREPARATION
07/10/2003WO2003055492A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
07/10/2003WO2003055477A1 Method for the treatment of mc receptor related disorders with a chelate and/or a chelator
07/10/2003WO2003050119A3 Urea substituted imidazopyridines
07/10/2003WO2003015872A3 Intravaginal administration of an aromatase inhibitor for the treatment of oestrogen-dependent proliferative disorders
07/10/2003WO2002101392A3 Methods for treating disorders of the nervous and reproductive systems
07/10/2003WO2002063008A3 Intracellular signaling molecules
07/10/2003US20030130505 Nonsteroidal agonists and antagonists
07/10/2003US20030130495 G-protein coupled receptors, signal transduction pathways
07/10/2003US20030130355 Serotonin/noradrenaline reuptake inhibitors (N-(1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutyl)-N,N-dimethylamine; dietetics; side effects reduction
07/10/2003US20030130337 Indole derivatives as anti-inflammatory agents
07/10/2003US20030130333 Combination product and methods of use
07/10/2003US20030130309 Antiinflammatory agents; rheumatic diseases
07/10/2003US20030130289 Inhibitors of glycogen synthase kinase 3
07/10/2003US20030130282 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
07/10/2003US20030130244 Mixture of estrogen, androgen and anticholinergic agent
07/10/2003US20030130243 Hormone replacement therapy
07/10/2003US20030130237 Lysophosphatidic acid receptor antagonist; anticancer agents
07/10/2003US20030130218 Methods of stimulating phagocytosis
07/10/2003US20030129241 Effective amount of a vasoactive prostaglandin, a polysaccharide thickener, a lipophilic component, and an acidic buffer system
07/10/2003US20030129235 Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
07/10/2003US20030129203 Rep proteins; fusion proteins; high throughput assay; gene therapy
07/10/2003US20030129129 Prevention, therapy disease; forming tritiated water; calibration
07/10/2003CA2471306A1 Secreted proteins
07/10/2003CA2471300A1 Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std)
07/10/2003CA2471297A1 Human netrin receptor and uses thereof
07/10/2003CA2470666A1 Secreted protein
07/10/2003CA2469690A1 Beta-amyloid binding factors and inhibitors thereof
07/09/2003EP1325930A1 Mammal prolactin variants
07/09/2003EP1325914A1 Tetrahydroquinoline compounds
07/09/2003EP1325131A2 A human-protein coupled receptor, hgprbmy6, expressed highly in small intestine
07/09/2003EP1325008A1 Piperazine derivatives
07/09/2003EP1325007A2 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
07/09/2003EP1325001A1 Anticholinergic agents that can be used as medicaments and method for the production thereof
07/09/2003EP1324998A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
07/09/2003EP1324995A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
07/09/2003EP1324992A1 Cyclized benzamide neurokinin antagonists for use in therapy
07/09/2003EP1324985A1 Inhibitors of prenyl-protein transferase
07/09/2003EP1324773A2 Use of a ppar delta activator in the treatment of diseases related to no inhibition or tnf inhibition
07/09/2003EP1324772A2 Methods for treating disorders of the female reproductive system
07/09/2003EP1324764A2 Method for inducing onset of the reproductive cycle of female breeding animals
07/09/2003EP1324754A1 Pharmaceutical combination of an anti-androgen and tamoxifen for providing an anti-androgenic effect and aromatase inhibition
07/09/2003EP0868188B1 Kit for female mammals, comprising a combination of gestagen and oestrogen
07/09/2003EP0823906B1 Piperazino derivatives as neurokinin antagonists
07/09/2003CN1429113A Nutritional preparation comprising ribose and folic acid and medical use thereof
07/09/2003CN1429104A Inhibitors type 5 and type 3 17 beta-hydroxysteroid dehydrogenase and methods for their use
07/09/2003CN1113648C Use of tetrahydro-beta-carboline derivative as antimetastatic carcinoma preparation
07/08/2003US6589990 Topically administering to penis to treat sexual disorder
07/08/2003US6589564 Magnesium lactate, magnesium asparate, magnesium acetate, magnesium pyrophosphate
07/08/2003CA2226784C Use of cgmp-phosphodiesterase inhibitors to treat impotence
07/08/2003CA2131553C Use of alkylureas and hydroxyurea as contraceptive agents
07/03/2003WO2003054141A2 Sperm-specific cation channel, catsper2, and uses therefor
07/03/2003WO2003054012A2 Leptin proteins
07/03/2003WO2003053977A1 Tetracyclic heterocompounds as estrogen receptor modulators
07/03/2003WO2003053939A1 Benzimidazole derivatives and their use as gnrh antagonists
07/03/2003WO2003053928A1 Serotonine reuptake inhibitor
07/03/2003WO2003053923A2 Pyrrolidine derivatives as prostaglandin modulators
07/03/2003WO2003053444A1 New use
07/03/2003WO2003053443A1 Substituted diketopiperazines as oxytocin antagonists
07/03/2003WO2003053441A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
07/03/2003WO2003053438A1 Use of anastrozole for the treatment of post-menopausal women having early breast cancer
07/03/2003WO2003053437A1 Triazoles as oxytocin antagonists
07/03/2003WO2003053358A2 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
07/03/2003WO2003053354A2 Fused cyclic modulators of nuclear hormone receptor function
07/03/2003WO2003053334A2 Compositions and methods for the diagnosis and treatment of tumor
07/03/2003WO2003053330A2 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer’s disease and conditions associated with glycogen synthase kinase-3
07/03/2003WO2003053292A1 Vaginal delivery of drugs
07/03/2003WO2003053219A2 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003WO2002101009A3 Structural and cytoskeleton-associated proteins
07/03/2003WO2002050279A3 Nucleic acid-associated proteins
07/03/2003WO2002018389A3 Thienopyrimidine
07/03/2003US20030125559 Methods for synthesizing ether compounds and intermediates therefor
07/03/2003US20030125390 Method of treatment and prophylaxis
07/03/2003US20030125387 Antioestrogens, capable of eliciting complete ablation of the trophic effects of oestrogens; cancer therapy
07/03/2003US20030125368 (1,2,4) triazol-1-yl)-benzenesulfonyl derivatives useful to treat osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals; cyclooxygenase (COX)-2 inhibitor
07/03/2003US20030125361 1H-benzo(g)indazole compounds as anticarcinogenic agents and also treat arthritis
07/03/2003US20030125344 Rho-kinase inhibitors
07/03/2003US20030125339 Substituted alkylamine derivatives and methods of use
07/03/2003US20030125335 Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
07/03/2003US20030125334 5-HT receptor ligands and uses thereof
07/03/2003US20030125330 Anxiolytics and antidepressants
07/03/2003US20030125319 Administering an estrogen agonist/ antagonist while reducing the side effects associated with estrogen administration; urinary and vaginal infections; incontinence; vaginal dryness; kits for assessing vaginal health
07/03/2003US20030125282 Treating fertility disorders; maternal-antigen-that-embryos-require (MATER)
07/03/2003US20030125259 Administering to the mammal a therapeutically acceptable amount of a octa or nonapeptide compound to inhibit the angiogenesis
07/03/2003US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein
07/03/2003US20030124620 Mullerian inhibiting substance levels and ovarian response
1 ... 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 ... 557